{"id":7417,"date":"2025-04-10T09:06:33","date_gmt":"2025-04-10T09:06:33","guid":{"rendered":"https:\/\/tst.incliva.es\/?page_id=7417"},"modified":"2025-04-10T09:06:33","modified_gmt":"2025-04-10T09:06:33","slug":"research-group-on-rare-respiratory-diseases-rrd","status":"publish","type":"page","link":"https:\/\/tst.incliva.es\/en\/que-hacemos\/areas\/metabolismo-y-dano-organico\/research-group-on-rare-respiratory-diseases-rrd\/","title":{"rendered":"Research Group on Rare Respiratory Diseases (RRD)"},"content":{"rendered":"

\n
\n

Research Group on Rare Respiratory Diseases (RRD)<\/h3>\n<\/div>\n
<\/div><\/div>\n
Metabolism and Organic Damage Area<\/span><\/h5>\n<\/div>\n
<\/div><\/div>\n
\n
\n We have shown that NK and lymphocytes B express and secrete alpha-1 antitrypsin <\/p>\n

We have discovered a group of miRNAs that could be used for the diagnosis and prognosis of alpha-1 antitrypsin deficiency. We are currently validating these results using an external cohort <\/p>\n

A new method based on oxidative stress markers to identify patients with Primary Ciliary Dyskinesia has been set up <\/p>\n

We have set up the high-speed video method to identify patients with Primary Ciliary Dyskinesia <\/p>\n

We have shown that hypoxia modifies neutrophil degranulation and enhances oxidative damage in alpha-1 antitrypsin deficiency patients
\n\n<\/div>\n<\/div>\n<\/div><\/div>